Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 8Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1408Neoplasms 1142Prostatic Neoplasms 750Lung Neoplasms 626Colorectal Neoplasms 604Carcinoma, Non-Small-Cell Lung 574Carcinoma, Hepatocellular 414Pancreatic Neoplasms 410Leukemia, Myeloid, Acute 399Stomach Neoplasms 365Multiple Myeloma 324Ovarian Neoplasms 313Brain Neoplasms 313Head and Neck Neoplasms 289Neoplasm Metastasis 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 263Rectal Neoplasms 257Recurrence 253Uterine Cervical Neoplasms 249Melanoma 245Esophageal Neoplasms 244Squamous Cell Carcinoma of Head and Neck 236Glioblastoma 232Lymphoma 214Sarcoma 209Colonic Neoplasms 195Urinary Bladder Neoplasms 194Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 186

Interventions

mirdametinib 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Lymphatic Abnormalities × Clear all
NCT05983159 2026-05-05

TARGET-VM

Murdoch Childrens Research Institute

Phase 2 Recruiting
50 enrolled

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations

NCT06892964 2025-03-25

IReg-LM

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting
70 enrolled

Lymphangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡